DENTSPLY SIRONA Files 8-K: Reg FD & Financials

Ticker: XRAY · Form: 8-K · Filed: 2025-09-08T00:00:00.000Z

Sentiment: neutral

Topics: regulatory-disclosure, financials, 8-k

TL;DR

DENTSPLY SIRONA dropped an 8-K on Sept 8th covering Reg FD and financials. Check it out.

AI Summary

DENTSPLY SIRONA Inc. filed an 8-K on September 8, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing pertains to the company's operations as of September 8, 2025, with its principal executive offices located in Charlotte, North Carolina.

Why It Matters

This filing provides important updates on DENTSPLY SIRONA's regulatory disclosures and financial reporting, which are crucial for investors to assess the company's current standing.

Risk Assessment

Risk Level: low — This is a routine filing of an 8-K for regulatory and financial disclosures, not indicating any immediate or significant adverse events.

Key Numbers

Key Players & Entities

FAQ

What specific event triggered this 8-K filing?

The filing is for a Regulation FD Disclosure and Financial Statements and Exhibits as of September 8, 2025.

What is the primary business of DENTSPLY SIRONA Inc. according to the filing?

The company is in the DENTAL EQUIPMENT & SUPPLIES industry, with SIC code 3843.

Where are DENTSPLY SIRONA Inc.'s principal executive offices located?

The principal executive offices are located at 13320 Ballantyne Corporate Place, Charlotte, North Carolina 28277-3607.

What is the fiscal year end for DENTSPLY SIRONA Inc.?

The fiscal year end is December 31 (1231).

What is the telephone number provided for DENTSPLY SIRONA Inc.?

The registrant's telephone number is (844) 848-0137.

From the Filing

0000818479-25-000167.txt : 20250908 0000818479-25-000167.hdr.sgml : 20250908 20250908083306 ACCESSION NUMBER: 0000818479-25-000167 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250908 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250908 DATE AS OF CHANGE: 20250908 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DENTSPLY SIRONA Inc. CENTRAL INDEX KEY: 0000818479 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 391434669 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-16211 FILM NUMBER: 251298674 BUSINESS ADDRESS: STREET 1: 13320 BALLANTYNE CORPORATE PLACE CITY: CHARLOTTE STATE: NC ZIP: 28277-3607 BUSINESS PHONE: 844-546-3722 MAIL ADDRESS: STREET 1: 13320 BALLANTYNE CORPORATE PLACE CITY: CHARLOTTE STATE: NC ZIP: 28277-3607 FORMER COMPANY: FORMER CONFORMED NAME: DENTSPLY INTERNATIONAL INC /DE/ DATE OF NAME CHANGE: 19930630 FORMER COMPANY: FORMER CONFORMED NAME: GENDEX CORP DATE OF NAME CHANGE: 19920703 8-K 1 xray-20250908.htm 8-K xray-20250908 0000818479 false 0000818479 2025-09-08 2025-09-08 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 September 8, 2025 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 13320 Ballantyne Corporate Place, Charlotte North Carolina 28277-3607 (Address of principal executive offices) (Zip Code) ( 844 ) 848-0137 (Registrant’s telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share XRAY The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Item 7.01    Regulation FD Disclosure On September 8, 2025, DENTSPLY SIRONA Inc. (the “Company”) issued a press release announcing that it has completed its previously disclosed process to evaluate strategic alternatives for its Wellspect Healthcare business (“Wellspect”) and the Company’s Board of Directors has determined that Wellspect will continue to operate within the Company’s portfolio. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information furnished pursuant to this Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange

View on Read The Filing